Document:

QuickLinks
 -- Click here to rapidly navigate through this document
  

Exhibit 4.3  

 
  AMENDMENT NO. 1 TO
  AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT    
    

        THIS AMENDMENT NO. 1 TO AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (the
"Amendment") is made and entered into as of this            day of April, 2004, by and among FAVRILLE,
INC., a Delaware corporation (the "Company"), and the investors listed on  Schedule A attached hereto (each of which is
referred to herein as an "Investor" and all of which
are collectively referred to herein as the "Investors"). 

 
 

RECITALS    
    

        WHEREAS, concurrently herewith, the Company and certain of the Investors have entered into that certain Amendment
No. 1 to Series C Preferred Stock Purchase Agreement (the "Purchase Amendment") pursuant to which the Company is selling and issuing, and
the New Investors (as defined in the Purchase Amendment) are purchasing, an aggregate of                        shares of the
Company's Series C Preferred Stock, par value $0.001 per share (the
"Additional Shares"); 

        WHEREAS, the Company and the Investors (other than the New Investors) are parties to that certain Amended and Restated Investor Rights
Agreement dated March 26, 2004 (the "Investor Rights Agreement"). Any capitalized term used in this Amendment and not defined herein shall have
the meaning assigned to such term in the Investor Rights Agreement; 

        WHEREAS, Section 3.7 of the Investor Rights Agreement provides that the Investor Rights Agreement may be amended only with the
written consent of (i) the Company, (ii) the holders of a majority of the Registrable Securities then outstanding, (iii) the holders of 662/3% of the
Series A Stock then outstanding, (iv) the holders of 662/3% of the Series B Stock and the Series B-2 Stock then outstanding, voting together as a
single class, and (v) the holders of 51% of the Series C Stock then outstanding; and 

        WHEREAS, in connection with the consummation of the transactions contemplated by the Purchase Amendment, the parties to the Investor
Rights Agreement wish to amend the Investor Rights Agreement to cause each of the New Investors to become a party to the Investor Rights Agreement. 

 
 

AGREEMENT    
    

        NOW THEREFORE, in consideration of the foregoing promises and the mutual covenants set forth herein, the Company
and the Investors agree as follows: 

1.     AMENDMENT OF INVESTOR RIGHTS AGREEMENT.  

        (a)   Effective as of the Second Closing Date (as defined in the Purchase Amendment), each of the New Investors shall become a
party to the Investor Rights Agreement and shall be deemed both an "Investor" and a "Holder" for purposes of the Investor Rights Agreement, and the shares of Series C Stock purchased by such
New Investors shall be deemed "Registrable Securities" for purposes of the Investor Rights Agreement. 

        (b)   The Company and the Investors hereby agree that the provisions of Section 2.5 of the Investor Rights Agreement
shall not apply to the offer or sale of the Additional Shares to the New Investors. 

2.    COUNTERPARTS.    This Amendment may be executed in any number of counterparts,
each of which shall be an original, but all of which together shall constitute one instrument. 

3.    NO OTHER CHANGES.    Except as otherwise provided herein, all the terms and
conditions of the Agreement which are not inconsistent herewith shall remain in full force and effect and shall apply equally to this Amendment. 

[THE
REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK] 

1

        IN WITNESS WHEREOF, the parties hereto have executed this AMENDMENT NO. 1 TO AMENDED AND RESTATED INVESTOR
RIGHTS AGREEMENTas of the date set forth in the first paragraph hereof. 

	 	FAVRILLE, INC.
	

 	

By:	

 	

 
	 	 	/s/  JOHN P. LONGENECKER      
 John P. Longenecker

President and Chief Executive Officer
	

 	

Address:	

10421 Pacific Center Court Suite 150 San Diego, CA 92121
	 	Fax:	(858) 526-8000
	

 	
INVESTORS:
	

 	
WILLIAM BLAIR CAPITAL PARTNERS VII, L.P.
	

 	

By:	

William Blair Capital Management VII, L.P.

Its: General Partner
	

 	

By:	

William Blair Capital Management VII, L.L.C.
	 	Its:	General Partner
	

 	

By:	

 	

 
	 	 	/s/  A.M. MINOCHERHOMJEE      

	 	Name:	Arda Minocherhomjee
	 	Its:	Managing Director
	

 	

Address:	

227 West Monroe Street

Suite 3500

Chicago, Illinois 60606
	

 	

Fax:	

(312) 236-5782

[SIGNATURE
PAGE TO AMENDMENT NO. 1 TO

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT] 

	 	WILLIAM BLAIR CAPITAL PARTNERS VII QP, L.P.
	

 	

By:	

William Blair Capital Management VII, L.P.
	 	Its:	General Partner
	

 	

By:	

William Blair Capital Management VII, L.L.C.
	 	Its:	General Partner
	

 	

By:	

 	

 
	 	 	/s/  A.M. MINOCHERHOMJEE      

	 	Name:	Arda Minocherhomjee
	 	Its:	Managing Director
	

 	

Address:	

227 West Monroe Street

Suite 3500

Chicago, Illinois 60606
	 	Fax:	(312) 236-5782
	

 	
ALLOY PARTNERS 2000, L.P.

ALLOY VENTURES 2000, L.P.

ALLOY CORPORATE 2000, L.P.

ALLOY INVESTORS 2000, L.P.
	

 	

By:	

Alloy Ventures 2000, LLC
	 	Their:	General Partner
	

 	

/s/  DOUGLAS E. KELLY      
 Managing Member of Alloy Ventures 2000, LLC
	

 	

Address:	

480 Cowpers Street

2nd Floor

Palo Alto, CA 94301
	 	Fax:	(650) 687-5010

[SIGNATURE
PAGE TO AMENDMENT NO. 1 TO

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT] 

	 	ALLOY ANNEX I, L.P.
	

 	

By:	

Alloy Annex I, LLC
	 	Its:	General Partner
	

 	

/s/  DOUGLAS E. KELLY      
 Managing Member of Alloy Annex I, LLC
	

 	

Address:	

480 Cowpers Street, 2nd Floor

Palo Alto, CA 94301
	

 	
DE NOVO VENTURES I, LP

DE NOVO (Q) VENTURES I, LP
	

 	

By:	

De Novo Management LLC
	 	Their:	General Partner
	

 	

/s/  FRED DOTZLER      
 Fred Dotzler, Managing Director
	

 	

Address:	

1550 El Camino Real

Suite 150

Menlo Park, CA 94025
	 	Fax:	(650) 329-1315

[SIGNATURE
PAGE TO AMENDMENT NO. 1 TO

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT] 

	 	SANDERLING VENTURE PARTNERS V, L.P.

SANDERLING V BIOMEDICAL, L.P.

SANDERLING V LIMITED PARTNERSHIP

SANDERLING V BETEILIGUNGS GMBH & CO. KG

SANDERLING VENTURE PARTNERS V CO-INVESTMENT FUND, L.P.

SANDERLING V BIOMEDICAL CO-INVESTMENT FUND, L.P.
	

 	

By:	

Middleton, McNeil & Mills Associates V, LLC
	

 	

/s/  FRED MIDDLETON      
 Fred A. Middleton

Managing Director
	

 	

Address:	

400 South El Camino Real

Suite 1200

San Mateo, CA 94402
	 	Fax:	(650) 375-7077
	

 	
SANDERLING V VENTURES MANAGEMENT
	

 	

/s/  FRED MIDDLETON      
 Fred A. Middleton

Owner
	

 	

Address:	

400 South El Camino Real

Suite 1200

San Mateo, CA 94402
	 	Fax:	(650) 375-7077

[SIGNATURE
PAGE TO AMENDMENT NO. 1 TO

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT] 

	 	FORWARD VENTURES III INSTITUTIONAL PARTNERS L.P.
	

 	

By:	

Forward III Associates, LLC
	

 	

By:	

 	

 
	 	 	/s/  IVOR ROYSTON      

	 	Name:	 	 
	 	 	Ivor Royston, M.D.

	 	Title:	 	 
	 	 	Managing Member

	

 	

Address:	

9393 Towne Centre Drive

Suite 200

San Diego, CA 92121
	 	Fax:	(858) 452-8799
	

 	
FORWARD VENTURES III L.P.
	

 	

By:	

Forward III Associates, LLC
	

 	

By:	

 	

 
	 	 	/s/  IVOR ROYSTON      

	 	Name:	 	 
	 	 	Ivor Royston, M.D.

	 	Title:	 	 
	 	 	Managing Member

	

 	

Address:	

9393 Towne Centre Drive

Suite 200

San Diego, CA 92121
	 	Fax:	(858) 452-8799
	

 	
FORWARD VENTURES IV B L.P.
	

 	

By:	

Forward IV Associates, LLC
	

 	

By:	

 	

 
	 	 	/s/  IVOR ROYSTON      

	 	Name:	 	 
	 	 	Ivor Royston, M.D.

	 	Title:	 	 
	 	 	Managing Member

	

 	

Address:	

9393 Towne Centre Drive

Suite 200

San Diego, CA 92121
	 	Fax:	(858) 452-8799

[SIGNATURE
PAGE TO AMENDMENT NO. 1 TO

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT] 

	 	FORWARD VENTURES IV L.P.
	

 	

By:	

Forward IV Associates, LLC
	

 	

By:	

 	

 
	 	 	/s/  IVOR ROYSTON      

	 	Name:	 	 
	 	 	Ivor Royston, M.D.

	 	Title:	 	 
	 	 	Managing Member

	

 	

Address:	

9393 Towne Centre Drive

Suite 200

San Diego, CA 92121
	 	Fax:	(858) 452-8799
	

 	
JACOBS INVESTMENT COMPANY, LLC
	

 	

By:	

 	

 
	 	 	/s/  GARY E. JACOBS      

	 	Name:	 	 
	 	 	Gary E. Jacobs

	 	Title:	 	 
	 	 	Manager

	

 	

Address:	

13974 Boquito Drive

Del Mar, CA 92014
	

 	
STEPHEN J. KANDEL SSB ROTH CONVERSION IRA CUST.
	

 	

By:	

 	

 
	 	 	

	 	Name:	Stephen J. Kandel
	 	Title:	Beneficial Owner
	

 	

Address:	

1021 Muirlands Drive

La Jolla, CA 92037
	

 	

    
 SANDEN KANDEL
	

 	

Address:	

1021 Muirlands Drive

La Jolla, CA 92037

[SIGNATURE
PAGE TO AMENDMENT NO. 1 TO

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT] 

	 	EBR HOLDINGS II LTD.
	

 	

By:	

 	

 
	 	 	

	 	Name:	 	 
	 	 	

	 	Title:	 	 
	 	 	

	

 	

Address:	

3366 N. Torrey Pines Ct.

Suite 210

La Jolla, CA 92037
	

 	

    
 ELLIOT FEUERSTEIN
	

 	

Address:	

8588 Ruette Monte Carlo

La Jolla, CA 92037
	

 	
MICHAEL M. BERNS LIVING TRUST

DATED 10/16/90, MICHAEL M. BERNS,

TRUSTEE
	

 	

By:	

 	

 
	 	 	
 Michael M. Berns

Trustee
	

 	

Address:	

1617 Emerald Bay

Laguna Beach, CA 92651
	

 	
THE PAYNE FAMILY TRUST DATED 1/23/85, ERROL G. PAYNE AND NAOMI F. PAYNE, TRUSTEES
	

 	

By:	

 	

 
	 	 	
 Errol G. Payne and Naomi F. Payne

Trustees
	

 	

Address:	

21 Ritz Cove Drive

Dana Point, CA 92629

[SIGNATURE
PAGE TO AMENDMENT NO. 1 TO

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT] 

	

 	

    
 JOSHUA COHEN AND LITA COHEN
	

 	

Address:	

8010 Frost Street, Suite 408

San Diego, CA 92123
	

 	
MICHAEL S. GROSSMAN UBS IRA ROLLOVER DG87091-68
	

 	

By:	

 	

 
	 	 	/s/  MICHAEL S. GROSSMAN      

	 	Name:	Michael S. Grossman
	 	Title:	Owner
	

 	

Address:	

310 Forward Street

La Jolla, CA 92037
	

 	
MARGARET GROSSMAN UBS IRA DG44753
	

 	

By:	

 	

 
	 	 	/s/  MARGARET STEVENS GROSSMAN      

	 	Name:	Margaret Grossman
	 	Title:	Owner
	

 	

Address:	

310 Forward Street

La Jolla, CA 92037
	

 	

    
 GUILIO WASSMER
	

 	

Address:	

Schlyffistrasse 15

8806 Bäch

Switzerland
	

 	

/s/  CHRISTOPH DIETSCHE      
 CHRISTOPH DIETSCHE
	

 	

Address:	

Jurastrasse 27

CH-5000 Aarau

Switzerland

[SIGNATURE
PAGE TO AMENDMENT NO. 1 TO

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT] 

	 	WARNKE BROADLEY KENNEDY FAMILY TRUST DATED 3/29/89, JOSEPH F. KENNEDY, TRUSTEE, GERIANN WARNKE, TRUSTEE
	

 	

By:	

 	

 
	 	 	/s/  JOSEPH F. KENNEDY      

	 	Name:	Joseph F. Kennedy
	 	Title	Trustee
	

 	

Address:	

6390 Cardeno Drive

La Jolla, CA 92037
	

 	
IRA M. LECHNER & WINIFRED EILEEN HAAG FAMILY TRUST DATED 1/21/00: IRA M. LECHNER & WINIFRED EILEEN HAAG TRUSTEES
	

 	

By:	

 	

 
	 	 	/s/  IRA M. LECHNER      

	 	Name:	 	 
	 	 	Ira M. Lechner

	 	Title:	 	 
	 	 	Trustee

	

 	

Address:	

19811 4th Place

Escondido, CA 92029
	

 	
MORGAN STANLEY DW INC. CUSTODIAN FOR IRA M. LECHNER (MSDW TAX ID #94-1671384)
	

 	

By:	

 	

 
	 	 	/s/  IRA M. LECHNER      

	 	Name:	Ira M. Lechner
	 	Title:	Trustee
	

 	

Address:	

19811 4th Place

Escondido, CA 92029

[SIGNATURE
PAGE TO AMENDMENT NO. 1 TO

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT] 

	

 	

    
 NEVINS MCBRIDE
	

 	

Address:	

 
	 	 	 	

	

 	

 	

 	

	

 	
ALFRED AND ADELE SALEH FAMILY TRUST
	

 	

By:	

 	

 
	 	 	

	 	Name:	Fred Saleh
	 	Title:	 	 
	 	 	

	

 	

Address:	

14845 Caminito Lorren

Del Mar, CA 92014
	

 	

    
 LAWRENCE BIER
	

 	

Address:	

13 Blueberry Ridge Court

Rockville, MD 20854
	

 	
DENNIS FAMILY TRUST DATED 3/29/93, EDWARD A. DENNIS, TRUSTEE, MARTHA G. DENNIS, TRUSTEE
	

 	

By:	

 	

 
	 	 	/s/  EDWARD A. DENNIS,   

/s/  MARTHA G. DENNIS      
 Edward A. Dennis and

Martha G. Dennis

Trustees
	

 	

Address:	

1921 Hypatia Way

La Jolla, CA 92037
	

 	

/s/  ELLIOTT ROYSTON      
 ELLIOTT ROYSTON
	

 	

Address:	

1634 Ponce de Leon Ave., #207

Atlanta, GA 30307

[SIGNATURE
PAGE TO AMENDMENT NO. 1 TO

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT] 

	

 	

    
 DAVID W. ODMARK
	

 	

Address:	

 
	 	 	 	

	

 	

 	

 	

	

 	
INDOFIN, NV
	

 	

By:	

 	

 
	 	 	

	 	Name:	Pieter van Dongen
	 	Title:	Director
	

 	

Address:	

c/o Avobone S.A.

9, Place du Bourg-de-Four

1204 Geneva

Switzerland

1204
	

 	

    
 HOWARD ALTMANN
	

 	

Address:	

P.O. Box 1965

New York, NY 10013
	

 	
LOTUS BIOSCIENCE INVESTMENT HOLDINGS LIMITED
	

 	

By:	

 	

 
	 	 	

	 	Name:	Wong Ken Lum and

Mong Cheuk Wai
	 	Title:	Directors
	

 	

Address:	

9th Floor, Central Building

Pedder Street, Hong Kong

[SIGNATURE
PAGE TO AMENDMENT NO. 1 TO

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT] 

	

 	
MERCER REVOCABLE FAMILY TRUST DTD 7/13/89
	

 	

By:	

 	

 
	 	 	

	 	Name:	Thomas Mercer
	 	Title:	Trustee
	

 	

Address:	

P.O. Box 842

Rancho Santa Fe, CA 92067
	

 	
WEIL FAMILY TRUST OF 1980,

CHRISTOPHER WEIL AND PATRICIA WEIL
	

 	

By:	

 	

 
	 	 	/s/  CHRISTOPHER WEIL      

	 	Name:	Christopher Weil
	 	Title:	Trustee
	

 	

Address:	

12555 High Bluff Dr.

San Diego, CA 92130

[SIGNATURE
PAGE TO AMENDMENT NO. 1 TO

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT] 

	 	GC&H INVESTMENTS
	

 	

By:	

 	

 
	 	 	/s/  JOHN L. CARDOZA      

	 	Name:	John L. Cardoza
	 	Title:	Executive Partner
	

 	

Address:	

One Maritime Plaza

20th Floor

San Francisco, CA 94111
	

 	
GC&H INVESTMENTS, LLC
	

 	

By:	

 	

 
	 	 	/s/  JOHN L. CARDOZA      

	 	Name:	John L. Cardoza
	 	Title:	Executive Partner
	

 	

Address:	

One Maritime Plaza

20th Floor

San Francisco, CA 94111
	

 	
GRAY GHOST, LLC
	

 	

By:	

 	

 
	 	 	/s/  PHILIP GOELET      

	 	Name:	 	 
	 	 	Philip Goelet

	 	Title:	Manager
	

 	

Address:	

c/o Red Abbey, LLC

2330 West Joppa Road

Suite 330

Lutherville, MD 21093
	 	Fax:	(410) 494-4247

[SIGNATURE
PAGE TO AMENDMENT NO. 1 TO

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT] 

	 	HELLER FINANCIAL LEASING, INC.
	

 	

By:	

 	

 
	 	 	/s/  MARK KING      

	 	Name:	Mark King
	 	Title:	Sr. Vice President
	

 	

Address:	

500 W. Monroe Street

Chicago, IL 60661

Attn: GE Technology Finance—Portfolio Management
	 	Fax:	(312) 876-2593
	

 	
PRIVATE EQUITY HOLDING-FAVRILLE, L.L.C.
	

 	

By:	

Howard Hughes Medical Institute
	 	Its:	Sole Member and Manager
	

 	

By:	

 	

 
	 	 	/s/  MARK A. BARNARD      

	 	Name:	 	 
	 	 	Mark A. Barnard

	 	Title:	 	 
	 	 	Managing Director

	

 	

Address:	

4000 Jones Bridge Road

Chevy Chase, MD 20815
	 	Fax:	(301) 215-8691
	

 	
SFP BIOTECH PARTNERS
	

 	

By:	

 	

 
	 	 	/s/  STEVEN LEE YAMSHON      
 Steven Lee Yamshon

Managing Partner
	

 	

Address:	

1851 E. First Street #150

Santa Ana, CA 92705

[SIGNATURE
PAGE TO AMENDMENT NO. 1 TO

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT] 

	 	STEPHEN J. KANDEL SSB ROTH

CONVERSION IRA CUST.
	

 	

By:	

 	

 
	 	 	/s/  STEPHEN J. KANDEL      

	 	Name:	Stephen J. Kandel
	 	Title:	Beneficial Owner
	

 	

Address:	

1021 Muirlands Drive

La Jolla, CA 92037
	

 	

/s/  STEPHEN J. KANDEL      
 STEPHEN AND GENEVIEVE KANDEL
	

 	

Address:	

P.O. Box 1891

Rancho Santa Fe, CA 92067

[SIGNATURE
PAGE TO AMENDMENT NO. 1 TO

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT] 

	 	OAKWOOD MEDICAL MANAGEMENT IV (QP), L.L.C.
	

 	

By:	

Oakwood Medical Management IV, L.L.C.
	 	Its:	Manager
	

 	

By:	

 	

 
	 	 	

	 	Name:	Raul E. Perez, M.D.
	 	Title:	President
	

 	

Address:	

439 Kirkwood Road, Suite 208

St. Louis, Missouri 63122
	

 	

 	

 	

 
	 	OAKWOOD MEDICAL INVESTORS IV, L.L.C.
	

 	

By:	

Oakwood Medical Management IV, L.L.C.
	 	Its:	Manager
	

 	

By:	

 	

 
	 	 	

	 	Name:	Raul E. Perez, M.D.
	 	Title:	President
	

 	

Address:	

439 Kirkwood Road, Suite 208

St. Louis, Missouri 63122

[SIGNATURE
PAGE TO AMENDMENT NO. 1 TO

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT] 

	 	COMMUNITY INVESTMENT PARTNERS V L.P., LLLP
	

 	

By:	

CIP Management L.P., LLLP
	 	Its:	Managing General Partner
	

 	

By:	

 	

 
	 	 	

	 	Name:	Daniel A. Burkhardt
	 	Title:	Chairman of CIP Management, Inc., Managing General Partner of CIP Management L.P., LLLP
	

 	

Address:	

12555 Manchester Road

St. Louis, Missouri 63131
	

 	
PIPER JAFFRAY HEALTHCARE FUND IV, L.P.
	

 	

By:	

Piper Jaffray Healthcare Management IV, LLC
	 	Its:	General Partner
	

 	

By:	

 	

 
	 	 	/s/  HEATH LUKATCH      
 Heath Lukatch, Managing Director of Piper Jaffray Ventures Inc., its General
Partner
	

 	

Address:	

100 Spear Street, Suite 1600

San Francisco, CA 94105
	 	Fax:	(415) 979-9488

[SIGNATURE
PAGE TO AMENDMENT NO. 1 TO

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT] 

	 	AVTECH PORTFOLIO, L.P.
	

 	

By:	

AVTech Ventures II, LLC
	 	Its:	General Partner
	

 	

By:	

 	

 
	 	 	
 Gary L. Shields, Managing Member
	

 	

Address:	

1201 Camino Del Mar, Suite 215

Del Mar, CA 92014
	 	Fax:	(858) 356-3563
	

 	
MATTHEW C. & IRIS LYNN STRAUSS, CO-TRUSTEES OF STRAUSS FAMILY TRUST DTD. 6/5/92
	

 	

By:	

 	

 
	 	 	/s/  MATTHEW STRAUSS      

	 	Name:	Matthew C. Strauss
	 	Title	Co-Trustee
	

 	

Address:	

c/o MC Strauss Company

990 Highland Drive, Suite 200

Solana Beach, CA 92075
	 	Fax:	(858) 792-7834
	

 	
BOSTON LIFE SCIENCE VENTURE CORP.
	

 	

By:	

 	

 
	 	 	/s/  KENNETH LO      

	 	Name:	Kenneth C.M. Lo
	 	Title:	Chairman
	

 	

Address:	

5th Fl. No. 420

Fu-Hsin N. Road

Taipei, Taiwan

[SIGNATURE
PAGE TO AMENDMENT NO. 1 TO

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT] 

	

 	
THOMAS A. SHIFTAN AND MAUREEN E. SHIFTAN, CO-TRUSTEES OF SHIFTAN FAMILY TRUST DTD. 3/23/98
	

 	

By:	

 	

 
	 	 	/s/  THOMAS SHIFTAN      

	 	Name:	Thomas A. Shiftan
	 	Title	Co-Trustee
	

 	

Address:	

7040 Neptune Place

La Jolla, CA 92037

[SIGNATURE
PAGE TO AMENDMENT NO. 1 TO

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT] 

	 	NEEDHAM CAPITAL SBIC III, L.P.

NEEDHAM CAPITAL PARTNERS IIIA, L.P.

NEEDHAM CAPITAL PARTNERS III (BERMUDA), L.P.
	

 	

By:	

 	

 
	 	 	/s/  JOHN J. PRIOR, JR.      

	 	Name:	 	 
	 	 	John J. Prior, Jr.

	 	Title:	 	 
	 	 	General Partner

	

 	

Address:	

Needham Asset Management

445 Park Avenue

New York, NY 10022

[SIGNATURE
PAGE TO AMENDMENT NO. 1 TO

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT] 

	 	1998 CO-INVESTING LLC

EIN 43-1831139
	

 	

By:	

 	

 
	 	 	/s/  JEFFREY MCDONNELL      

	 	Name:	Jeff McDonnell
	 	Title	Title Manager
	

 	

Address:	

1034 S. Brentwood, Suite 1860

St. Louise, MO 63117
	

 	
SCHRODERS & CO. BANK SA
	

 	

By:	

 	

 
	 	 	/s/  SAMUEL MOULIN      

	 	Name:	 	 
	 	 	Samuel Moulin

	 	Title:	 	 
	 	 	Director

	

 	

Address:	

8, Rue D'Italie

Geneve, Switzerland

[SIGNATURE
PAGE TO AMENDMENT NO. 1 TO

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT] 

	

 	

/s/  ERIC W. ROBERTS      
 ERIC W. ROBERTS
	

 	

Address:	

205 E 78th St., #4H

New York, NY 10022
	

 	
SCHEIBLER-LEHENY FAMILY LIVING TRUST U/D/T JUNE 6, 2001
	

 	

By:	

 	

 
	 	 	/s/  EDWARD M. SCHEIBLER      

	

 	

By:	

 	

 
	 	 	/s/  A. RACHEL LEHENY      

	

 	

Names:	

Edward G. Scheibler, Trustee

A. Rachel Leheny, Trustee
	

 	

Address:	

 
	 	 	 	P.O. Box 647

	

 	

 	

 	

Rancho Santa Fe, CA 92067

	

 	

 	

 	

	

 	
THE NICHOLAS & PADDI ARTHUR TRUST DATED 4-14-98
	

 	

By:	

 	

 
	 	 	/s/  NICHOLAS ARTHUR      

	

 	

By:	

 	

 
	 	 	/s/  PADDI ARTHUR      

	

 	

Names:	

Nicholas Arthur, Co-Trustee

Paddi Arthur, Co-Trustee
	

 	

Address:	

 
	 	 	 	

	

 	

 	

 	

	

 	

 	

 	

[SIGNATURE
PAGE TO AMENDMENT NO. 1 TO

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT] 

 
 

SCHEDULE A    
    
    INVESTORS    
    

INVESTOR  

William
Blair Capital Partners VII, L.P. 

William
Blair Capital Partners VII QP, L.P. 

Alloy
Partners 2000, L.P. 

Alloy
Ventures 2000, L.P. 

Alloy
Corporate 2000, L.P. 

Alloy
Investors 2000, L.P. 

Alloy
Annex I, L.P. 

De
Novo Ventures I, LP 

De
Novo (Q) Ventures I, LP 

Sanderling
Venture Partners V, L.P. 

Sanderling
V Biomedical, L.P. 

Sanderling
V Limited Partnership 

Sanderling
V Beteiligungs GmbH & Co. KG 

Sanderling
V Ventures Management 

Sanderling
Venture Partners V Co-Investment Fund, L.P. 

Sanderling
V Biomedical Co-Investment Fund, L.P. 

Forward
Ventures III Institutional Partners L.P. 

Forward
Ventures III L.P. 

Forward
Ventures IV B L.P. 

Forward
Ventures IV L.P. 

Jacobs
Investment Company, LLC 

Stephen
J. Kandel SSB Roth Conversion IRA Cust. 

Sanden
Kandel 

EBR
Holdings II Ltd. 

Elliot
Feuerstein 

Michael
M. Berns Living Trust Dated 10/16/90, Michael M. Berns, Trustee 

The
Payne Family Trust Dated 1/23/85, Errol G. Payne and Naomi F. Payne, Trustees 

Joshua
Cohen and Lita Cohen 

Michael
S. Grossman UBS IRA Rollover DG87091-68 

Margaret
Grossman UBS IRA DG44753 

Guilio
Wassmer 

Christoph
Dietsche 

Warnke
Broadley Kennedy Family Trust Dated 3/29/89, Joseph F. Kennedy, Trustee, Geriann Warnke, Trustee 

Ira
M. Lechner & Winifred Eileen Haag Family Trust Dated 1/21/00: Ira M. Lechner & Winifred Eileen Haag Trustees 

Morgan
Stanley DW Inc. Custodian for Ira M. Lechner (MSDW Tax ID #94-1671384) 

Nevins
McBride 

Alfred
and Adele Saleh Family Trust 

Lawrence
Bier 

Dennis
Family Trust Dated 3/29/93, Edward A. Dennis, Trustee, Martha G. Dennis, Trustee 

Elliott
Royston 

David
W. Odmark 

Indofin,
NV 

Howard
Altmann 

Lotus
Bioscience Investment Holdings Limited 

Mercer
Revocable Family Trust DTD 7/13/89 

Weil
Family Trust of 1980, Christopher Weil and Patricia Weil 

GC&H
Investments 

GC&H
Investments, LLC 

Gray
Ghost, LLC 

Heller
Financial Leasing, Inc. 

SFP
Biotech Partners 

Schroders
& Co. Bank SA 

Antonio
J. Grillo-Lopez and Maria S. Grillo Trustees Grillo-Marxuach Family Trust dated 6-28-95 

Private
Equity Holding-Favrille, L.L.C. 

Stephen
Kandel CGM Roth Conversion IRA CUST A/C #119-51879-17-380 

Stephan
and Genevieve Kandel 

Oakwood
Medical Investors IV (QP), L.L.C. 

Oakwood
Medical Investors IV, L.L.C. 

Community
Investment Partners V L.P., LLLP 

Piper
Jaffray Healthcare Fund IV, L.P. 

AVTech
Portfolio, L.P. 

Matthew
C. & Iris Strauss, co-trustees of Strauss Family Trust dtd. 6/5/92 

Boston
Life Science Venture Corp. 

Thomas
A. Shiftan and Maureen E. Shiftan, co-trustees of Shiftan Family Trust dated 3/23/98 

[ADD NEW SERIES C INVESTORS]  

QuickLinks

AMENDMENT NO. 1 TO AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

RECITALS

AGREEMENT

SCHEDULE A INVESTORSQuickLinks
 -- Click here to rapidly navigate through this document

Exhibit 10.1  

 
 

FAVRILLE, INC.
  INDEMNITY AGREEMENT    
    

        THIS INDEMNITY AGREEMENT (this "Agreement") is made and entered
into this [    ] day of [            ], 2004 by and between FAVRILLE, INC., a
Delaware corporation (the "Company"), and [                        ]
("Agent"). 

 
 

RECITALS    
    

        WHEREAS, Agent performs a valuable service to the Company in  [his/her] capacity as
[                        ] of the Company; 

        WHEREAS, the Company's Amended and Restated Bylaws (the "Bylaws"), which were approved by
the stockholders of the Company, provide for the indemnification of the directors, officers, employees and other agents of the Company, including persons serving at the request of the Company in such
capacities with other corporations or enterprises, as authorized by the Delaware General Corporation Law (the "DGCL"); 

        WHEREAS, the Bylaws and the DGCL, by their non-exclusive nature, permit contracts between the Company and its agents,
officers, employees and other agents with respect to indemnification of such persons; and 

        WHEREAS, in order to induce Agent to continue to serve as [                        ] of the
Company, the Company has
determined and agreed to enter into this Agreement with Agent. 

        NOW, THEREFORE, in consideration of Agent's continued service as [                        ]
after the date hereof, the
parties hereto agree as follows: 

 
 

AGREEMENT    
    

        1.    Services to the Company.    Agent will serve, at the will of the
Company or under separate contract, if any such contract exists, as [                        ] of the Company or as a director,
executive officer or other fiduciary of an affiliate of
the Company (including any employee benefit plan of the Company) faithfully and to the best of Agent's ability so long as Agent is duly elected and qualified in accordance with the provisions of the
Bylaws or other applicable charter documents of the Company or such affiliate; provided, however, that Agent may at any time and for any reason resign
from such position (subject to any contractual obligation that Agent may have assumed apart from this Agreement) and that the Company or any affiliate shall have no obligation under this Agreement to
continue Agent in any such position. 

        2.    Indemnity of Agent.    The Company hereby agrees to hold
harmless and indemnify Agent to the fullest extent authorized or permitted by the provisions of the Bylaws and the DGCL, as the same may be amended from time to time (but only to the extent that such
amendment permits the Company to provide broader indemnification rights than the Bylaws or the DGCL permitted prior to adoption of such amendment). 

        3.    Additional Indemnity.    In addition to and not in limitation of
the indemnification otherwise provided for herein, and subject only to the exclusions set forth in Section 4 hereof, the Company hereby further agrees to hold harmless and indemnify Agent: 

        (a)   against any and all expenses (including attorneys' fees), witness fees, damages, judgments, fines and amounts paid in
settlement and any other amounts that Agent becomes legally obligated to pay because of any claim or claims made against or by Agent in connection with any threatened, pending or completed action,
suit or proceeding, whether civil, criminal, arbitrational, administrative or investigative (including an action by or in the right of the Company) to which Agent is, was or at any time becomes a
party, or is threatened to be made a party, by reason of 

 

the
fact that Agent is, was or at any time becomes a director, officer, employee or other agent of the Company, or is or was serving or at any time serves at the request of the Company as a director,
officer, employee or other agent of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise; and 

        (b)   otherwise to the fullest extent as may be provided to Agent by the Company under the non-exclusivity
provisions of the DGCL and Section 43(e) of the Bylaws. 

        4.    Limitations on Additional Indemnity.    No indemnity pursuant to
Section 3 hereof shall be paid by the Company: 

        (a)   on account of any claim against Agent solely for an accounting of profits made from the purchase or sale by Agent of
securities of the Company pursuant to the provisions of Section 16(b) of the Securities Exchange Act of 1934, as amended, or similar provisions of any federal, state or local statutory law; 

        (b)   on account of Agent's conduct that is established by a final judgment as knowingly fraudulent or deliberately dishonest
or that constituted willful misconduct; 

        (c)   on account of Agent's conduct that is established by a final judgment as constituting a breach of Agent's duty of loyalty
to the Company or resulting in any personal profit or advantage to which Agent was not legally entitled; 

        (d)   for which payment is actually made to Agent under a valid and collectible insurance policy or under a valid and
enforceable indemnity clause, bylaw or agreement, except in respect of any excess beyond payment under such insurance, clause, bylaw or agreement; 

        (e)   if indemnification is not lawful (and, in this respect, both the Company and Agent have been advised that the Securities
and Exchange Commission believes that indemnification for liabilities arising under the federal securities laws is against public policy and is, therefore, unenforceable and that claims for
indemnification should be submitted to appropriate courts for adjudication); or 

        (f)    in connection with any proceeding (or part thereof) initiated by Agent, or any proceeding by Agent against the Company or
its directors, officers, employees or other agents, unless (i) such indemnification is expressly required to be made by law, (ii) the proceeding was authorized by the Board of Directors
of the Company, (iii) such indemnification is provided by the Company, in its sole discretion, pursuant to
the powers vested in the Company under the DGCL, or (iv) the proceeding is initiated pursuant to Section 9 hereof. 

        5.    Continuation of Indemnity.    All agreements and obligations of
the Company contained herein shall continue during the period Agent is a director, officer, employee or other agent of the Company (or is or was serving at the request of the Company as a director,
officer, employee or other agent of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise) and shall continue thereafter so long as Agent shall be subject
to any possible claim or threatened, pending or completed action, suit or proceeding, whether civil, criminal, arbitrational, administrative or investigative, by reason of the fact that Agent was
serving in the capacity referred to herein. 

        6.    Partial Indemnification.    Agent shall be entitled under this
Agreement to indemnification by the Company for a portion of the expenses (including attorneys' fees), witness fees, damages, judgments, fines and amounts paid in settlement and any other amounts that
Agent becomes legally obligated to pay in connection with any action, suit or proceeding referred to in Section 3 hereof even if not entitled hereunder to indemnification for the total amount
thereof, and the Company shall indemnify Agent for the portion thereof to which Agent is entitled. 

2

 

        7.    Notification and Defense of Claim.    Not later than
30 days after receipt by Agent of notice of the commencement of any action, suit or proceeding, Agent will, if a claim in respect thereof is to be made against the Company under this Agreement,
notify the Company of the commencement thereof; but the omission so to notify the Company will not relieve it from any liability which it may have to Agent otherwise than under this Agreement. With
respect to any such action, suit or proceeding as to which Agent notifies the Company of the commencement thereof: 

        (a)   the Company will be entitled to participate therein at its own expense; 

        (b)   except as otherwise provided below, the Company may, at its option and jointly with any other indemnifying party
similarly notified and electing to assume such defense, assume the defense thereof, with counsel reasonably satisfactory to Agent. After notice from the Company to Agent of its election to assume the
defense thereof, the Company will not be liable to Agent under this Agreement for any legal or other expenses subsequently incurred by Agent in connection with the defense thereof except for
reasonable costs of investigation or otherwise as provided below. Agent shall have the right to employ separate counsel in such action, suit or proceeding but the fees and expenses of such counsel
incurred after notice from the Company of its assumption of the defense thereof shall be at the expense of Agent unless (i) the employment of counsel by Agent has been authorized by the
Company, (ii) Agent shall have reasonably concluded, and so notified the Company, that there is an actual conflict of interest between the Company and Agent in the conduct of the defense of
such action or (iii) the Company shall not in fact have employed counsel to assume the defense of such action, in each of
which cases the fees and expenses of Agent's separate counsel shall be at the expense of the Company. The Company shall not be entitled to assume the defense of any action, suit or proceeding brought
by or on behalf of the Company or as to which Agent shall have made the conclusion provided for in clause (ii) above; and 

        (c)   the Company shall not be liable to indemnify Agent under this Agreement for any amounts paid in settlement of any action
or claim effected without its written consent, which shall not be unreasonably withheld. The Company shall be permitted to settle any action except that it shall not settle any action or claim in any
manner which would impose any penalty or limitation on Agent without Agent's written consent, which may be given or withheld in Agent's sole discretion. 

        8.    Expenses.    The Company shall advance, prior to the final
disposition of any proceeding, promptly following request therefor, all expenses incurred by Agent in connection with such proceeding upon receipt of an undertaking by or on behalf of Agent to repay
said amounts if it shall be determined ultimately that Agent is not entitled to be indemnified under the provisions of this Agreement, the Bylaws, the DGCL or otherwise. 

        9.    Enforcement.    Any right to indemnification or advances granted
by this Agreement to Agent shall be enforceable by or on behalf of Agent in any court of competent jurisdiction if (i) the claim for indemnification or advances is denied, in whole or in part,
or (ii) no disposition of such claim is made within 90 days of request therefor. Agent, in such enforcement action, if successful in whole or in part, shall be entitled to be paid also
the expense of prosecuting Agent's claim. It shall be a defense to any action for which a claim for indemnification is made under Section 3 hereof (other than an action brought to enforce a
claim for expenses pursuant to Section 8 hereof, provided that the required undertaking has been tendered to the Company) that Agent is not
entitled to indemnification because of the limitations set forth in Section 4 hereof. Neither the failure of the Company (including its Board of Directors or its stockholders) to have made a
determination prior to the commencement of such enforcement action that indemnification of Agent is proper in the circumstances, nor an actual determination by the Company (including its Board of
Directors or its stockholders) that such indemnification is improper shall be a defense to the action or create a presumption that Agent is not entitled to indemnification under this Agreement or
otherwise. 

3

 

        10.    Subrogation.    In the event of payment under this Agreement,
the Company shall be subrogated to the extent of such payment to all of the rights of recovery of Agent, who shall execute all documents required and shall do all acts that may be necessary to secure
such rights and to enable the Company effectively to bring suit to enforce such rights. 

        11.    Non-Exclusivity of Rights.    The rights conferred
on Agent by this Agreement shall not be exclusive of any other right which Agent may have or hereafter acquire under any statute, provision
of the Company's Amended and Restated Certificate of Incorporation or Bylaws, each as may be amended from time to time, agreement, vote of stockholders or directors, or otherwise, both as to action in
Agent's official capacity and as to action in another capacity while holding office. 

        12.    Survival of Rights.    

        (a)   The rights conferred on Agent by this Agreement shall continue after Agent has ceased to be a director, officer, employee
or other agent of the Company or to serve at the request of the Company as a director, officer, employee or other agent of another corporation, partnership, joint venture, trust, employee benefit plan
or other enterprise and shall inure to the benefit of Agent's heirs, executors and administrators. 

        (b)   The Company shall require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to
all or substantially all of the business or assets of the Company expressly to assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required
to perform if no such succession had taken place. 

        13.    Separability.    Each of the provisions of this Agreement is a
separate and distinct agreement and independent of the others, so that if any provision hereof shall be held to be invalid for any reason, such invalidity or unenforceability shall not affect the
validity or enforceability of the other provisions hereof. Furthermore, if this Agreement shall be invalidated in its entirety on any ground, then the Company shall nevertheless indemnify Agent to the
fullest extent provided by the Bylaws, the DGCL or any other applicable law. 

        14.    Governing Law.    This Agreement shall be interpreted and
enforced in accordance with the laws of the State of Delaware. 

        15.    Amendment and Termination.    No amendment, modification,
termination or cancellation of this Agreement shall be effective unless in writing signed by both parties hereto. 

        16.    Identical Counterparts; Facsimile.    This Agreement may be
executed in one or more counterparts, each of which shall for all purposes be deemed to be an original but all of which together shall constitute but one and the same Agreement. Only one such
counterpart need be produced to evidence the existence of this Agreement. Facsimile signatures shall be as effective as original signatures. 

        17.    Headings.    The headings of the sections of this Agreement are
inserted for convenience only and shall not be deemed to constitute part of this Agreement or to affect the construction hereof. 

        18.    Notices.    All notices, requests, demands and other
communications hereunder shall be in writing and shall be deemed to have been duly given (i) upon delivery if delivered by hand to the party to whom such communication was directed,
(ii) when sent by confirmed electronic mail, with verification of receipt, or by facsimile, in either case, if sent during regular business hours; if not, then on the next business day; or
(iii) upon the third business day after the date on which such communication was mailed if mailed by certified or registered mail, return receipt requested, with postage prepaid 

4

 

        (a)   All communications shall be delivered to Agent at the address indicated on the signature page hereof, or at such other
address as Agent shall designate by ten days' advance written notice to the Company. 

        (b)   All communications shall be delivered to the Company at 10421 Pacific Center Court, Suite 150, San Diego, California
92121, or such other address as may have been furnished to Agent by the Company. 

5

        IN WITNESS WHEREOF, the parties hereto have executed this Agreement on and as of the day and year first above written. 

	 	 	FAVRILLE, INC.
	

 	
 	

By:	
 	

          

	 	 	Title:	 	          

	

 	
 	
AGENT
	

 	
 	

	

 	
 	

Address:
	

 	
 	

	

 	
 	

[SIGNATURE
PAGE TO INDEMNITY AGREEMENT] 

QuickLinks

FAVRILLE, INC. INDEMNITY AGREEMENT

RECITALS

AGREEMENT

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00064-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00064-of-00352.parquet"}]]